Ocular HSV-1 latency, reactivation and recurrent disease

Keyphrases

• Herpes Simplex Virus Type 1 (HSV-1) 100%
• Recurrent Disease 100%
• HSV-1 Latency 100%
• Latency Reactivation 100%
• Ocular Infection 33%
• Virus 16%
• Clinical Data 16%
• Chemotherapy 16%
• Saliva 16%
• Virology 16%
• Host Factors 16%
• Anti-inflammatory Therapy 16%
• Latency 16%
• Latently Infected 16%
• Viral Factors 16%
• Viral Shedding 16%
• Opacity 16%
• Latent Infection 16%
• Viral Proteins 16%
• Tears 16%
• Primary Infection 16%
• Reactivation from Latency 16%
• Infection Site 16%
• Ganglion 16%
• Viral Genome 16%
• Epithelial Keratitis 16%
• Blindness 16%
• Conjunctivitis 16%
• Ocular Diseases 16%
• Neovascularization 16%
• Clinical Problems 16%
• Corneal Scar 16%
• Ocular Tissues 16%
• Latency-associated Transcript 16%
• Anterograde Transport 16%
• Region Encoding 16%
• Trigeminal Ganglion 16%
• Corneal Diseases 16%
• Blepharitis 16%
• Herpetic Disease 16%
• Neural Reactivation 16%
• HSV-1 Reactivation 16%
• Corneal Epithelial 16%
• Stromal Keratitis 16%

Medicine and Dentistry

• Recurrent Disease 100%
• Infection 66%
• Keratitis 66%
• Eye Infection 66%
• Ganglion 66%
• Lifespan 33%
• Virus 33%
• Antivirus Agent 33%
• Eye Disease 33%
• Anti-Inflammatory Drug 33%
• Primary Infection 33%
• Virus Genome 33%
• Scar Formation 33%
• Conjunctivitis 33%
• Virus Shedding 33%
• Blepharitis 33%
• Viral Protein 33%
• Antiviral Drug 33%
• Cornea Disease 33%
• Diseases 33%